Steven D. Harr
2021 - Sana Biotechnology
In 2021, Steven D. Harr earned a total compensation of $1.2M as President, Chief Executive Officer, and Director at Sana Biotechnology, a 83% decrease compared to previous year.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Non-Equity Incentive Plan | $375,000 |
| Salary | $611,154 |
| Total | $1,186,154 |
Harr received $611.2K in salary, accounting for 52% of the total pay in 2021.
Harr also received $200K in bonus and $375K in non-equity incentive plan.
Rankings
In 2021, Steven D. Harr's compensation ranked 8,166th out of 12,415 executives tracked by ExecPay. In other words, Harr earned more than 34.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,166 out of 12,415 | 34th |
Division Manufacturing | 3,613 out of 5,505 | 34th |
Major group Chemicals And Allied Products | 1,607 out of 2,375 | 32nd |
Industry group Drugs | 1,429 out of 2,096 | 32nd |
Industry Biological Products, Except Diagnostic Substances | 318 out of 449 | 29th |
Source: SEC filing on April 26, 2022.
Harr's colleagues
We found two more compensation records of executives who worked with Steven D. Harr at Sana Biotechnology in 2021.
News
Sana Biotechnology Former Executive Vice President and President, Research and Development Douglas Williams receives $3M in 2023
April 26, 2024
Sana Biotechnology General Counsel Bernard Cassidy receives $4M in 2022
April 28, 2023
Sana Biotechnology Chief Medical Officer Sunil Agarwal receives $1.9M in 2021
April 26, 2022